ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,222.68
0.16%
Dow Jones
39,512.84
0.32%
US Dollar vs MXN
16.7804
0.00%
Brent Oil
82.585
0.00%
Bitcoin
60,939.61
0.23%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Adial Pharmaceuticals Inc (ADILW)

  7. Adial Pharmaceuticals Inc (ADILW) Noticias

ADILW

Adial Pharmaceuticals (ADILW)

Adial Pharmaceuticals Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ADILW
FechaHoraFuenteTítuloSímboloCompañía
22/04/202407:30GlobeNewswire Inc.Adial Pharmaceuticals Granted Key Patent from the United States Patent and Trademark OfficeNASDAQ:ADILWAdial Pharmaceuticals Inc
10/04/202407:30GlobeNewswire Inc.Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use DisorderNASDAQ:ADILWAdial Pharmaceuticals Inc
02/04/202407:30GlobeNewswire Inc.Adial Pharmaceuticals Reports 2023 Fiscal Year Financial Results and Provides Business UpdateNASDAQ:ADILWAdial Pharmaceuticals Inc
01/03/202418:00GlobeNewswire Inc.Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross ProceedsNASDAQ:ADILWAdial Pharmaceuticals Inc
28/02/202408:30GlobeNewswire Inc.Adial Pharmaceuticals Awarded New Patent from the United States Patent and Trademark OfficeNASDAQ:ADILWAdial Pharmaceuticals Inc
13/02/202408:15GlobeNewswire Inc.Adial Pharmaceuticals Awarded New Patent Notice of Allowance from the United States Patent and Trademark OfficeNASDAQ:ADILWAdial Pharmaceuticals Inc
18/01/202407:30GlobeNewswire Inc.Adial Announces Appointment of Tony Goodman as Chief Operating OfficerNASDAQ:ADILWAdial Pharmaceuticals Inc
20/12/202308:00GlobeNewswire Inc.Adial Pharmaceuticals Receives Final Reimbursement Payment from AdovateNASDAQ:ADILWAdial Pharmaceuticals Inc
29/11/202315:05GlobeNewswire Inc.Adial Pharmaceuticals Regains Compliance with Nasdaq Listing RequirementNASDAQ:ADILWAdial Pharmaceuticals Inc
14/11/202316:02GlobeNewswire Inc.Adial Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:ADILWAdial Pharmaceuticals Inc
31/10/202307:30GlobeNewswire Inc.Adial Pharmaceuticals Chief Medical Officer and Key Opinion Leaders to Discuss “New Aspects in Substance Use Treatment” at The Annual International Society of Addiction Medicine ConferenceNASDAQ:ADILWAdial Pharmaceuticals Inc
25/10/202307:00GlobeNewswire Inc.Addiction Experts Highlight the Need for Non-Abstinence-Based Therapies to Treat Alcohol Use Disorder in Adial Pharmaceuticals Key Opinion Leader WebinarNASDAQ:ADILWAdial Pharmaceuticals Inc
24/10/202315:30GlobeNewswire Inc.Adial Pharmaceuticals Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq RulesNASDAQ:ADILWAdial Pharmaceuticals Inc
20/10/202307:00GlobeNewswire Inc.Adial Pharmaceuticals Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq RulesNASDAQ:ADILWAdial Pharmaceuticals Inc
19/10/202309:30GlobeNewswire Inc.Adial Pharmaceuticals Awarded Notice of Allowance for Key Patent Combining Use of the Company’s Proprietary Genetic Diagnostic with AD04 to Treat Alcohol and Drug DependenceNASDAQ:ADILWAdial Pharmaceuticals Inc
18/10/202307:00GlobeNewswire Inc.Adial Pharmaceuticals Wins Frost & Sullivan's 2023 North American Precision Medicine for Addiction Disorders Technology Innovation Leadership AwardNASDAQ:ADILWAdial Pharmaceuticals Inc
28/09/202306:00GlobeNewswire Inc.Adial Pharmaceuticals to Host a Virtual Key Opinion Leader Webinar to Discuss the Unmet Need in Alcohol Use DisorderNASDAQ:ADILWAdial Pharmaceuticals Inc
05/09/202307:30GlobeNewswire Inc.Adial Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:ADILWAdial Pharmaceuticals Inc
28/08/202307:30GlobeNewswire Inc.Adial Pharmaceuticals Chief Medical Officer and Key Opinion Leaders to Discuss the Need for New Alcohol Use Disorder Treatments at the European Society for Biomedical Research on AlcoholismNASDAQ:ADILWAdial Pharmaceuticals Inc
23/08/202307:30GlobeNewswire Inc.Adial Pharmaceuticals Regains Compliance with Nasdaq Listing RequirementsNASDAQ:ADILWAdial Pharmaceuticals Inc
21/08/202307:30GlobeNewswire Inc.Adial Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:ADILWAdial Pharmaceuticals Inc
04/08/202307:30GlobeNewswire Inc.Adial Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price Requirement and Reduce the Public FloatNASDAQ:ADILWAdial Pharmaceuticals Inc
11/07/202307:30GlobeNewswire Inc.Adial Provides Business Update Following Favorable Comments from US and EU Regulatory MeetingsNASDAQ:ADILWAdial Pharmaceuticals Inc
01/06/202308:00GlobeNewswire Inc.Adial Pharmaceuticals to Present at the 2023 Jefferies Global Healthcare Conference on June 9thNASDAQ:ADILWAdial Pharmaceuticals Inc
12/05/202307:30GlobeNewswire Inc.Adial Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:ADILWAdial Pharmaceuticals Inc
10/05/202307:30GlobeNewswire Inc.Adial Pharmaceuticals Receives Notice of Exercise from Adovate for the Acquisition of Purnovate’s Assets and BusinessNASDAQ:ADILWAdial Pharmaceuticals Inc
30/03/202315:05GlobeNewswire Inc.Adial Pharmaceuticals Reports 2022 Fiscal Year Financial Results and Provides Business UpdateNASDAQ:ADILWAdial Pharmaceuticals Inc
21/03/202308:00GlobeNewswire Inc.Adial Pharmaceuticals Engages The Keswick Group to Advance Partnering Activities for the Clinical Development of AD04 for Alcohol Use DisorderNASDAQ:ADILWAdial Pharmaceuticals Inc
08/03/202308:00GlobeNewswire Inc.Adial Pharmaceuticals to Present at the 35th Annual Roth Conference on March 14thNASDAQ:ADILWAdial Pharmaceuticals Inc
06/03/202315:19GlobeNewswire Inc.Adial Pharmaceuticals Provides Update on Regulatory Strategy for AD04 for Treatment of Alcohol Use DisorderNASDAQ:ADILWAdial Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ADILW

Su Consulta Reciente

TG
TUP
Tupperware Brands
NASDAQ
CJET
Chijet Motor
NASDAQ
MRVL
Marvell Technology
UNSW3
ZDEXETH
NYSE
DLW
Delta Woodside
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados